Compare
Pit 2–4 stocks against each other: U-Score, pillars, fundamentals, and normalized price history. Same universe, same methodology, one view.
| Metric | SUNREST Sunrest Lifescience Ltd. Pharma · SME | ONYX Onyx Biotec Ltd. Pharma · SME | CURIS Curis Lifesciences Ltd. Pharma · SME | SOTAC Sotac Pharmaceuticals Ltd. Pharma · SME |
|---|---|---|---|---|
| Final Score | 68 | 15 | 46 | 47 |
| Verdict | UNDERVALUED | OVERVALUED | FAIR VALUE | FAIR VALUE |
| Style | Deep Value | OVERVALUED | Deep Value | Growth at Value |
| Piotroski | 6/9 | 3/9 | 5/9 | 8/9 |
| Valuation | 29/30 | 6/30 | 24/30 | 15/30 |
| Growth | 24/25 | 7/25 | 18/25 | 21/25 |
| Quality | 14/20 | 0/20 | 0/20 | 0/20 |
| Balance Sheet | 6/15 | 9/15 | 9/15 | 9/15 |
| Cash Flow | 0/10 | 0/10 | 0/10 | 5/10 |
| Price | ₹34 | ₹42 | ₹110 | ₹111 |
| P/E | 7.08 | — | 16.60 | 21.30 |
| P/B | 1.43 | 1.41 | — | 2.08 |
| ROE | 22.40% | -0.38% | — | 10.30% |
| ROCE | 28.60% | 1.14% | — | 12.60% |
| Debt / Equity | 0.85 | 0.27 | 0.00 | 0.64 |
| FCF Yield | — | — | — | 8.13% |
| Dividend Y | — | — | — | 0.09% |
| Altman Z | 2.23 | 2.78 | 0.00 | 2.87 |
| Promoter % | 53.50% | 65.10% | 68.03% | 72.85% |
| Mkt Cap (₹Cr) | 29.20 | 78.00 | 88.90 | 123.00 |
| Graham # | ₹50.7 | — | — | ₹79.12 |
| Fair PE | 42.0 | 23.5 | 42.0 | 42.0 |
| MoS % | +83.1% | — | +97.5% | +49.4% |
Normalized price (3-year, indexed to 100)
Higher line = better relative performance from startSUNREST50
ONYX74
CURIS78
SOTAC87